Skip to main content
SpringerLink
Log in

Sympathomimetika

  • Chapter
Glaukom

  • 51 Accesses

Zusammenfassung

Epinephrin (Adrenalin) ist ein direkt wirksames Sympathomimetikum, das auf α- und β-adrenerge Rezeptoren wirkt und ein Standardantiglaukomatosum für die Dauertherapie der Offenwinkelglaukome darstellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Goldmann, H: L’origine de l’hypertension oculaire dans leglaucome primitif. Ann Ocul (Paris) 184:1086, 1951.

    CAS  Google Scholar 

  2. Weekers, R, Prijot, E, Gustin, J: Recent advances and future prospects in the medical treatment of ocular hypertension. Br J Ophthal 38:742, 1954.

    CAS  Google Scholar 

  3. Weekers, R, Delmarcelle, Y, Gustin, J: Treatment of ocular hypertension by adrenalin and diverse sympathomimetic amines. Am J Ophthal 40:666, 1955.

    PubMed  CAS  Google Scholar 

  4. Becker, B, Ley, AP: Epinephrine and acetazolamide in the therapy of the chronic glaucomas. Am J Ophthal 45:639, 1958.

    PubMed  CAS  Google Scholar 

  5. Garner, LL, Johnstone, WW, Ballintine, EJ, Carroll, ME: Effect of 2% levo-rotary epinephrine on the intraocular pressure of the glaucomatous eye. Arch Ophthal 62:230, 1959.

    CAS  Google Scholar 

  6. Becker, B, Pettit, TH, Gay, AJ: Topical epinephrine therapy of open-angle glaucoma. Arch Ophthal 66:219, 1961.

    PubMed  CAS  Google Scholar 

  7. Ballintine, EJ, Garner, LL: Improvement of the coefficient of outflow in glaucomatous eyes. Prolonged local treatment with epinephrine. Arch Ophthal 66:314, 1961.

    PubMed  CAS  Google Scholar 

  8. Kronfeld, PC: Dose-effect relationships as an aid in the evaluation of ocular hypotensive drugs. Invest Ophthal 3:258, 1964.

    PubMed  CAS  Google Scholar 

  9. Krill, AE, Newell, FW, Novak, M: Early and long-term effects of levo-epinephrine on ocular tension and outflow. Am J Ophthal 59:833, 1965.

    PubMed  CAS  Google Scholar 

  10. Criswick, VG, Drance, SM: Comparative study of four different epinephrine salts on intraocular pressure. Arch Ophthal 75:768, 1966.

    PubMed  CAS  Google Scholar 

  11. Richards, JSF, Drance, SM: The effect of 2% epinephrine on aqueous dynamics in the human eye. Can J Ophthal 2:259, 1967.

    CAS  Google Scholar 

  12. Kronfeld, PC: Early effects of single and repeated doses of L-epinephrine in man. Am J Ophthal 72:1058, 1971.

    PubMed  CAS  Google Scholar 

  13. Vannas, S, Linkova, M: Adrenalin therapy in glaucoma. Acta Ophthalmologica XX Meeting of Nordic Ophthalmo logists 1971, p. 39.

    Google Scholar 

  14. Green, K, Padgett, D: Effect of various drugs on pseudofacility and aqueous humor formation in the rabbit eye. Exp Eye Res 28:239, 1979.

    PubMed  CAS  Google Scholar 

  15. Townsend, DJ, Brubaker, RF: Immediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorophotometry. Invest Ophthal Vis Sci 19:256,1980.

    PubMed  CAS  Google Scholar 

  16. Nagataki, S, Brubaker, RF: Early effect of epinephrine on aqueous formation in the normal human eye. Ophthalmo logy 88:278, 1981.

    CAS  Google Scholar 

  17. Schenker, HI, Yablonski, ME, Podos, SM, Linder, L: Fluorophotometric study of epinephrine and timolol in human subjects. Arch Ophthal 99:1212, 1981.

    PubMed  CAS  Google Scholar 

  18. Sears, ML: The mechanism of action of adrenergic drugs in glaucoma. Invest Ophthal 5:115, 1966.

    CAS  Google Scholar 

  19. Sears, ML, Neufeld, AH: Adrenergic modulation of the outflow of aqueous humor. Invest Ophthal 14:83, 1975.

    PubMed  CAS  Google Scholar 

  20. Sears, ML: Autonomic Nervous System: Adrenergic Agonists. In: Handbook of Experimental Pharmacology, vol. 69, Sears, ML, ed. Springer-Verlag, Berlin, 1984.

    Google Scholar 

  21. Van Buskirk, EM: The ciliary vasculature and its perturbation with drugs and surgery. Trans Am Ophthal Soc 86:794, 1988.

    PubMed  Google Scholar 

  22. Aim, A: The effect of topical l-epinephrine on regional ocular blood flow in monkeys. Invest Ophthal Vis Sci 19:487, 1980.

    Google Scholar 

  23. Jay, WM, Aziz, MZ, Green, K: Further studies on the effect of retrobulbar epinephrine injection on ocular and opticnerve blood flow. Curr Eye Res 5:63, 1986.

    PubMed  CAS  Google Scholar 

  24. Lee, DA, Brubaker, RF, Nagataki, S: Acute effect of thymoxamine on aqueous humor formation in the epinephrine-treated normal eye as measured by fluorophotometry. Invest Ophthal Vis Sci 24:165, 1983.

    PubMed  CAS  Google Scholar 

  25. Higgins, RG, Brubaker, RF: Acute effect of epinephrine on aqueous humor formation in the timolol-treated normal eye as measured by fluorophotometry. Invest Ophthal Vis Sci 19:420, 1980.

    PubMed  CAS  Google Scholar 

  26. Wentworth, WO, Brubaker, RF: Aqueous humor dynamics in a series of patients with third neuron Horner’s syndrome. Am J Ophthal 92:407, 1981.

    PubMed  CAS  Google Scholar 

  27. Camras, CB, Feldman, SG, Podos, SM, et al: Inhibition of the epinephrine-induced reduction of intraocular pressure by systemic indomethacin in humans. Am J Ophthal 100:169, 1985.

    PubMed  CAS  Google Scholar 

  28. Miyake, K, Miyake, Y, Kuratomi, R: Long-term effects of topically applied epinephrine on the blood-ocular barrier in humans. Arch Ophthal 105:1360, 1987.

    PubMed  CAS  Google Scholar 

  29. Anderson, L, Wilson, WS: Inhibition by indomethacin of the increased facility of outflow induced by adrenaline. Exp Eye Res 50:119, 1990.

    PubMed  CAS  Google Scholar 

  30. Kaufman, PL, Barany, EH: Adrenergic drug effects on aqueous outflow facility following ciliary muscle retrodis-placement in the cynomolgus monkey. Invest Ophthal Vis Sci 20:644, 1981.

    PubMed  CAS  Google Scholar 

  31. Kaufman, PL: Epinephrine, norepinephrine, and isoproterenol dose-outflow facility response relation ships in cynomolgus monkey eyes with and without ciliary muscle retrodisplacement. Acta Ophthal 64:356, 1986.

    PubMed  CAS  Google Scholar 

  32. Robinson, JC, Kaufman, PL: Effects and interactions of epinephrine, norepinephrine, timolol, and betaxolol on outflow facility in the cynomolgus monkey. Am J Ophthal 109:189, 1990.

    PubMed  CAS  Google Scholar 

  33. Neufeld, AH, Sears, ML: Adenosine 31,51-monophosphate analogue increases the outflow facility of the primate eye. Invest Ophthal 14:688, 1975.

    PubMed  CAS  Google Scholar 

  34. Tripathi, BJ, Tripathi, RC: Effect of epinephrine in vitro on the morphology, phagocytosis, and mitotic activity of human trabecular endothelium. Exp Eye Res 39:731, 1984.

    PubMed  CAS  Google Scholar 

  35. Hayasaka, S, Sears, M: Effects of epinephrine, indomethacin, acetylsalicylic acid, dexamethasone, and cyclic AMP on the in vitro activity of lysosomal hyaluronidase from the rabbit iris. Invest Ophthal Vis Sci 17:1109,1978.

    PubMed  CAS  Google Scholar 

  36. Flach, AJ, Kramer, SG: Supersensitivity to topical epinephrine after long-term epinephrine therapy. Arch Ophthal 98:482, 1980.

    PubMed  CAS  Google Scholar 

  37. Harris, LS, Galin, MA, Lerner, R: The influence of low dose L-epinephrine on intraocular pressure. Ann Ophthal 2:253, 1970.

    Google Scholar 

  38. Vaughan, D, Shaffer, R, Riegelman, S: A new stabilized form of epinephrine for the treatment of open-angle glaucoma. Arch Ophthal 66:232, 1961.

    PubMed  CAS  Google Scholar 

  39. Birss, SA, Longwell, A, Heckbert, S, Keller, N: Ocular hypotensive efficacy of topical epinephrine in normotensive and hypertensive rabbits: continuous drug delivery vs eyedrops. Ann Ophthal 10:1045, 1978.

    PubMed  CAS  Google Scholar 

  40. Kaback, MB, Podos, SM, Hargin, TS Jr, et al: The effects of dipivalyl epinephrine on the eye. Am J Ophthal 81:768, 1976.

    PubMed  CAS  Google Scholar 

  41. Bigger, JF: Dipivefrin and glaucoma. Pers Ophthal 4:87, 1980.

    Google Scholar 

  42. Adamek, R: New perspectives in glaucoma therapy with epinephrine and epinephrine derivatives. Klin Monatsbl Augenheilkd 176:978, 1980.

    PubMed  CAS  Google Scholar 

  43. Mandell, AI, Stentz, F, Kitabchi, AE: Dipivalyl epinephri ne: a new pro-drug in the treatment of glaucoma. Ophthal mology 85:268, 1978.

    CAS  Google Scholar 

  44. Wei, C-P, Anderson, JA, Leopold, I: Ocular absorption and metabolism of topically applied epinephrine and dipivalyl ester of epinephrine. Invest Ophthal Vis Sci 17:315, 1978.

    PubMed  CAS  Google Scholar 

  45. Anderson, JA, Davis, WL, Wei, C-P: Site of ocular hydrolysis of a prodrug, dipivefrin, and a comparison of its ocular metabolism with that of the parent compound, epinephrine. Invest Ophthal Vis Sci 19:817, 1980.

    PubMed  CAS  Google Scholar 

  46. Tamaru, RD, Davis, WL, Anderson, JA: Comparison of ocular disposition of free pivalic acid and pivalic acid esterified in dipivefrin. Arch Ophthal 101:1127, 1983.

    PubMed  CAS  Google Scholar 

  47. Abramovsky, I, Mindel, JS: Dipivefrin and echothiophate. Contraindications to combined use. Arch Ophthal 97:1937, 1979.

    PubMed  CAS  Google Scholar 

  48. Anderson, JA, Richman, JB, Mindel, JS: Effects of echothiophate on enzymatic hydrolysis of dipivefrin. Arch Ophthal 102:913, 1984.

    PubMed  CAS  Google Scholar 

  49. Mindel, JS, Koenigsberg, AM, Kharlamb, AB, et al: The effect of echothiophate on the biphasic response of rabbit ocular pressure to dipivefrin. Arch Ophthal 100:147, 1982.

    PubMed  CAS  Google Scholar 

  50. Mindel, JS, Cohen, G, Barker, LA, Lewis, DE: Enzymatic and nonenzymatic hydrolysis of D,L-dipivefrin. Arch Ophthal 102:457, 1984.

    PubMed  CAS  Google Scholar 

  51. Mindel, JS, Yablonski, ME, Tavitian, HO, et al: Dipivefrin and echothiophate. Efficacy of combined use in human beings. Arch Ophthal 99:1583, 1981.

    PubMed  CAS  Google Scholar 

  52. Kass, MA, Mandell, AI, Goldberg, I, et al: Dipivefrin and epinephrine treatment of elevated intraocular pressure. A comparative study. Arch Ophthal 97:1865, 1979.

    PubMed  CAS  Google Scholar 

  53. Kohn, AN, Moss, AP, Hargett, NA, et al: Clinical comparison of dipivalyl epinephrine and epinephrine in the the treatment of glaucoma. Am J Ophthal 87:196, 1979.

    PubMed  CAS  Google Scholar 

  54. Bischoff, P: Clinical studies conducted with a new epinephrine derivative for the treatment of glaucoma (dipivalyl epinephrine). Klin Monatsbl Augenheilkd 172:565, 1978.

    PubMed  CAS  Google Scholar 

  55. Krieglstein, GK, Leydhecker, W: The dose-response relationships of dipivalyl epinephrine in open-angle glaucoma. Graefe’s Arch Ophthal 205:141, 1978.

    CAS  Google Scholar 

  56. Kerr, CR, Hass, I, Drance, SM, et al: Cardiovascular effects of epinephrine and dipivalyl epinephrine applied topically to the eye in patients with glaucoma. Br J Ophthal 66:109, 1982.

    CAS  Google Scholar 

  57. Yablonski, ME, Shin, DH, Kolker, AE, et al: Dipivefrin use in patients with intolerance to topically applied epinephri ne. Arch Ophthal 95:2157, 1977.

    PubMed  CAS  Google Scholar 

  58. Newton, MJ, Nesburn, AB: Lack of hydrophilic lens discoloration in patients using dipivalyl epinephrine for glaucoma. Am J Ophthal 87:193, 1979.

    PubMed  CAS  Google Scholar 

  59. Theodore, JA, Leibowitz, HM: External ocular toxicity of dipivalyl epinephrine. Am J Ophthal 88:1013, 1979.

    PubMed  CAS  Google Scholar 

  60. Wandel, T, Spinak, M: Toxicity of dipivalyl epinephrine. Ophthalmology 88:259, 1981.

    PubMed  CAS  Google Scholar 

  61. Liesegang, TJ: Bulbar conjunctival follicles associated with dipivefrin therapy. Ophthalmology 92:228, 1985.

    PubMed  CAS  Google Scholar 

  62. Coleiro, JA, Sigurdsson, H, Lockyer, JA: Follicular conjunctivitis on dipivefrin therapy for glaucoma. Eye 2:440, 1988.

    PubMed  Google Scholar 

  63. Holland, MG: Treatment of glaucoma by chemical sympa-thectomy with 6-hydroxydopamine. Trans Am Acad Ophthal Otol 76:437, 1972.

    CAS  Google Scholar 

  64. Holland, MG, Wei, C-P: Epinephrine dose-response characteristics of glaucomatous human eyes following chemical sympathectomy with 6-hydroxydopamine. Ann Ophthal 5:633, 1973.

    PubMed  CAS  Google Scholar 

  65. Holland, MG, Wei, C-P: Chemical sympathectomy in glaucoma therapy: an investigation of alpha and beta adrenergic supersensitivity. Ann Ophthal 5:783, 1973.

    PubMed  CAS  Google Scholar 

  66. Diamond, JG: 6-hydroxydopamine in treatment of openangle glaucoma. Arch Ophthal 94:41, 1976.

    PubMed  CAS  Google Scholar 

  67. Colasanti, BK, Kosa, JE, Trotter, RR: Responsiveness of the rabbit eye to adrenergic and cholinergic agonists after treatment with 6-hydroxydopamine or alpha-methyl-paratyrosine. Part I-Pupillary changes. Ann Ophthal 10:1067, 1978.

    PubMed  CAS  Google Scholar 

  68. Colasanti, BK, Trotter, RR: Responsiveness of the rabbit eye to adrenergic and cholinergic agonists after treatment with 6-hydroxydopamine or alpha-methyl-para-tyrosine. Part II-Intraocular pressure changes. Ann Ophthal 10:1209, 1978.

    PubMed  CAS  Google Scholar 

  69. Talusan, E, Schwartz, B, Mandell, AI, et al: 6-Hydroxydopamine in the treatment of open-angle glaucoma. Am J Ophthal 92:792, 1981.

    PubMed  CAS  Google Scholar 

  70. Kitazawa, Y, Nose, H, Horie, T: Chemical sympathectomy with 6-hydroxydopamine in the treatment of primary open angle glaucoma. Am J Ophthal 79:98, 1975.

    PubMed  CAS  Google Scholar 

  71. Watanabe, H, Levene, RZ, Bernstein, MR: 6-Hydroxydopamine therapy in glaucoma. Trans Am Acad Ophthal Otol 83:69, 1977.

    CAS  Google Scholar 

  72. Sneddon, JM, Turner, P: The interactions of local guanethidine and sympathomimetic amines in the human eye. Arch Ophthal 81:622, 1969.

    PubMed  CAS  Google Scholar 

  73. Bonomi, L, Di Comite, P: Outflow facility after guanethidine sulfate administration. Arch Ophthal 78:337, 1967.

    PubMed  CAS  Google Scholar 

  74. Crombie, AL: Adrenergic supersensitization as a therapeutic tool in glaucoma. Trans Ophthal Soc UK 94:570, 1974.

    PubMed  CAS  Google Scholar 

  75. Jones, DEP, Norton, DA, Harvey, J, Davies, DJG: Effect of adrenaline and guanethidine in reducing intraocular pressure in rabbits’ eyes. Br J Ophthal 59:304, 1975.

    CAS  Google Scholar 

  76. Nagasubramanian, S, Tripathi, RC, Poinoosawmy, D, Gloster, J: Low concentration guanethidine and adrenalinetherapy of glaucoma. A preliminary report. Trans Ophthal Soc UK 96:179, 1976.

    PubMed  CAS  Google Scholar 

  77. Mills, KB, Ridgway, AEA: A double blind comparison of guanethidine-and-adrenaline drops with 1% adrenaline alone in chronic simple glaucoma. Br J Ophthal 62:320, 1978.

    CAS  Google Scholar 

  78. Hoyng, PhFJ, Dake, CL: The combination of guanethidine 3% and adrenaline 0.5% in 1 eyedrop (GA) in glaucoma treatment. Br J Ophthal 63:56, 1979.

    CAS  Google Scholar 

  79. Romano, J, Patterson, G: Evaluation of a 5% guanethidine and 0.5% adrenaline mixture (Ganda 5.05) and of a3% guanethidine and 0.5% adrenaline mixture (Ganda 3.05) in the treatment of open-angle glaucoma. Br J Ophthal 63:52, 1979.

    CAS  Google Scholar 

  80. Jones, DEP, Norton, DA, Davies, DJG: Control of glaucoma by reduced dosage guanethidine-adrenaline formulation. Br J Ophthal 63:813, 1979.

    CAS  Google Scholar 

  81. Hoyng, PhFJ, Dake, CL: Maintenance therapy of glaucomapatients with guanethidine (3%) and adrenaline (0.5%) once daily. Graefe’s Arch Ophthal 214:269, 1980.

    CAS  Google Scholar 

  82. Van Husen, H: A combination of 1% guanethidine and 0.2% epinephrine in drop form to lower IOP in open angle glaucoma. Klin Monatsbl Augenheilkd 177:622, 1980.

    PubMed  Google Scholar 

  83. Murray, A, Glover, D, Hitchings, R: Low-dose combined guanethidine 1% and adrenaline 0.5% in the treatment of chronic simple glaucoma: a prospective study. Br J Ophthal 65:533, 1981.

    CAS  Google Scholar 

  84. Hitchings, RA, Glover, D: Adrenaline 1% combined with guanethidine 1% versus adrenaline 1%: a randomised prospective double-blind cross-over study. Br J Ophthal 66:247, 1982.

    CAS  Google Scholar 

  85. Romano, JH, Nagasubramanian, S, Poinoosawmy, D: Double-masked cross-over comparison of Ganda 1.02 (guanethidine 1% and adrenaline 0.2% mixture) with gutt. adrenaline 1% (Simplene 1%) and with pilocarpine 1% (Sno-Pilo 1%). Br J Ophthal 65:50, 1981.

    CAS  Google Scholar 

  86. Heilmann, K: Course of intraocular pressure during long-term treatment with a combination of guanethidine and epinephrine. Klin Monatsbl Augenheilkd 183:17, 1983.

    PubMed  CAS  Google Scholar 

  87. Hoyng, PhFJ, Dake, CL: The aqueous humor dynamics and the biphasic response in intraocular pressure induced by guanethidine and adrenaline in the glaucomatous eye. Graefe’s Arch Ophthal 214:263, 1980.

    CAS  Google Scholar 

  88. Gloster, J: Guanethidine and glaucoma. Trans Ophthal Soc UK 94:573, 1974.

    PubMed  CAS  Google Scholar 

  89. Asregadoo, ER: Guanethidine ophthalmic solution 5%. Use in the treatment of endocrine exophthalmos. Arch Ophthal 84:21, 1970.

    PubMed  CAS  Google Scholar 

  90. Riley, FC, Moyer, NJ: Experimental Homer’s syndrome: a pupillographic evaluation of guanethidine-induced adrenergic blockade in humans. Am J Ophthal 69:442, 1970.

    PubMed  CAS  Google Scholar 

  91. Urner-Bloch, U, Aeschlimann, JE, Gloor, BP: Treatment of chronic simple glaucoma with an adrenaline/guanethidine combination at three different dosages (comparative double-blind study). Graefe’s Arch Ophthal 213:175, 1980.

    CAS  Google Scholar 

  92. Keates, EU: Evaluation of timolol maleate combination therapy in chronic open-angle glaucoma. Am J Ophthal 88:565, 1979.

    PubMed  CAS  Google Scholar 

  93. Smith, RJ, Nagasubramanian, S, Watkins, R, Poinoosawmy, D: Addition of timolol maleate to routine medical therapy: a clinical trial. Br J Ophthal 64:779, 1980.

    CAS  Google Scholar 

  94. Nielsen, NV, Eriksen, JS: Timolol in maintenance treatment of ocular hypertension and glaucoma. Acta Ophthal 57:1070, 1979.

    PubMed  CAS  Google Scholar 

  95. Thomas, JV, Epstein, DL: Timolol and epinephrine in primary open angle glaucoma. Transient additive effect. Arch Ophthal 99:91, 1981.

    CAS  Google Scholar 

  96. Thomas, JV, Epstein, DL: Study of the additive effect of timolol and epinephrine in lowering intraocular pressure. Br J Ophthal 65:596, 1981.

    CAS  Google Scholar 

  97. Goldberg, I, Ashburn, FS Jr, Palmberg, PF, et al: Timolol and epinephrine. A clinical study of ocular interactions. Arch Ophthal 98:484, 1980.

    PubMed  CAS  Google Scholar 

  98. Keates, EC, Stone, RA: Safety and effectiveness of concomitant administration of dipivefrin and timolol maleate. Am J Ophthal 91:243, 1981.

    PubMed  CAS  Google Scholar 

  99. Ohrstrom, A, Pandolfi, M: Regulation of intraocular pressure and pupil size by beta-blockers and epinephrine. Arch Ophthal 98:2182, 1980.

    PubMed  CAS  Google Scholar 

  100. Ohrstrom, A, Kattstrom, O: Interaction of timolol and adrenaline. Br J Ophthal 65:53, 1981.

    CAS  Google Scholar 

  101. Knupp, JA, Shields, MB, Mandell, AI, et al: Combined timolol and epinephrine therapy for open angle glaucoma. Surv Ophthal 28(suppl):280, 1983.

    Google Scholar 

  102. Cyrlin, MS, Thomas, JV, Epstein, DL: Additive effect of epinephrine to timolol therapy in primary open angle glaucoma. Arch Ophthal 100:414, 1982.

    PubMed  CAS  Google Scholar 

  103. Korey, MS, Hodapp, E, Kass, MA, et al: Timolol and epinephrine. Long-term evaluation of concurrent administration. Arch Ophthal 100:742, 1982.

    PubMed  CAS  Google Scholar 

  104. Ober, M, Scharrer, A: The effect of timolol and dipivalyl-epinephrine in the treatment of the elevated intraocular pressure. Graefe’s Arch Ophthal 213:273, 1980.

    CAS  Google Scholar 

  105. Tsoy, EA, Meekins, BB, Shields, MB: Comparison of two treatment schedules for combined timolol and dipivefrin therapy. Am J Ophthal 102:320, 1986.

    PubMed  CAS  Google Scholar 

  106. Urtti, A, Kyyronen, K: Ophthalmic epinephrine, phenylephrine, and pilocarpine affect the systemic absorption of ocularly applied timolol. J Ocul Pharmacol 5:127, 1989.

    PubMed  CAS  Google Scholar 

  107. Allen, RC, Epstein, DL: Additive effect of betaxolol and epinephrine in primary open angle glaucoma. Arch Ophthal 104:1178, 1986.

    PubMed  CAS  Google Scholar 

  108. Weinreb, RN, Ritch, R, Kushner, FH: Effect of adding betaxolol to dipivefrin therapy. Am J Ophthal 101:196, 1986.

    PubMed  CAS  Google Scholar 

  109. Ohrstrom, A: Dose response of oral timolol combined with adrenaline. Br J Ophthal 66:242, 1982.

    CAS  Google Scholar 

  110. Anderson, JA: Systemic absorption of topical ocularly applied epinephrine and dipivefrin. Arch Ophthal 98:350, 1980.

    PubMed  CAS  Google Scholar 

  111. Corwin, ME, Spencer, WH: Conjunctival melanin depositions. A side-effect of topical epinephrine therapy. Arch Ophthal 69:73, 1963.

    Google Scholar 

  112. Veirs, ER, McGrew, JC: Ocular complications from topical epinephrine therapy of glaucoma. EENT Monthly 42:46, 1963.

    Google Scholar 

  113. Cashwell, LF, Shields, MB, Reed, JW: Adrenochrome pigmentation. Arch Ophthal 95:514, 1977.

    PubMed  CAS  Google Scholar 

  114. Pardos, GJ, Krachmer, JH, Mannis, MJ: Persistent corneal erosion secondary to tarsal adrenochrome deposit. Am J Ophthal 90:870, 1980.

    PubMed  CAS  Google Scholar 

  115. Pau, H, Schmitt-Graeff, A: Pigmented deposits into conjunctiva after local application of epinephrine. Graefe’s Arch Ophthal 216:69, 1981.

    CAS  Google Scholar 

  116. Reinecke, RD, Kuwabara, T: Corneal deposits secondary to topical epinephrine. Arch Ophthal 70:170, 1963.

    PubMed  CAS  Google Scholar 

  117. Krejci, L, Harrison, R: Corneal pigment deposits from topically administered epinephrine. Experimental production. Arch Ophthal 82:836, 1969.

    PubMed  CAS  Google Scholar 

  118. Green, WR, Kaufer, GJ, Dubroff, S: Black cornea. A complication of topical use of epinephrine. Ophthalmologica 154:88, 1967.

    PubMed  CAS  Google Scholar 

  119. Cleasby, G, Donaldson, DD: Epinephrine pigmentation of the cornea. Arch Ophthal 78:74, 1967.

    Google Scholar 

  120. Madge, GE, Geeraets, WJ, Guerry, DP III: Black cornea secondary to topical epinephrine. Am J Ophthal 71:402, 1971.

    PubMed  CAS  Google Scholar 

  121. McCarthy, RW, LeBlanc, R: A ‘black cornea’ secondary to topical epinephrine. Can J Ophthal 11:336, 1976.

    CAS  Google Scholar 

  122. Barishak, R, Romano, A, Stein, R: Obstruction of lacrimal sac caused by topical epinephrine. Ophthalmologica 159:373, 1969.

    PubMed  CAS  Google Scholar 

  123. Spaeth, GL: Nasolacrimal duct obstruction caused by topical epinephrine. Arch Ophthal 77:355, 1967.

    PubMed  CAS  Google Scholar 

  124. Bradbury, JA, Rennie, IG, Parsons, MA: Adrenaline dacryolith: detection by ultrasound examination of the nasolacrimal duct. Br J Ophthal 72:935, 1988.

    CAS  Google Scholar 

  125. Soong, HK, McKenney, MJ, Wolter, JR: Adrenochromestaining of senile plaque resembling malignant melanoma. Am J Ophthal 101:380, 1986.

    PubMed  CAS  Google Scholar 

  126. Sugar, J: Adrenochrome pigmentation of hydrophilic lenses. Arch Ophthal 91:11, 1974.

    PubMed  CAS  Google Scholar 

  127. Miller, D, Brooks, SM, Mobilia, E: Adrenochrome staining of soft contact lenses. Ann Ophthal 8:65, 1976.

    PubMed  CAS  Google Scholar 

  128. Romano, A, Barishak, R, Stein, R: Obstruction of lacrimal puncta caused by topical epinephrine. Ophthalmologica 166:301, 1973.

    PubMed  CAS  Google Scholar 

  129. Kass, MA, Stamper, RL, Becker, B: Madarosis in chronicepinephrine therapy. Arch Ophthal 88:429, 1972.

    PubMed  CAS  Google Scholar 

  130. Kristensen, EB, Norn, MS: Benign mucous membrane pemphigoid. 1. Secretion of mucus and tears. Acta Ophthal 52:266, 1974.

    PubMed  CAS  Google Scholar 

  131. Fiore, PM, Jacobs, IH, Goldberg, DB: Drug-induced pemphigoid. A spectrum of diseases. Arch Ophthal 105:1660, 1987.

    PubMed  CAS  Google Scholar 

  132. Tauber, J, Melamed, S, Foster, CS: Glaucoma in patients with ocular-cicatricial pemphigoid. Ophthalmology 96:33, 1989.

    PubMed  CAS  Google Scholar 

  133. Kwon, BS, Gangarosa, LP Sr, Green, K, Hill, JM: Kinetics of ocular herpes simplex virus shedding induced by epinephrine iontophoresis. Invest Ophthal Vis Sci 22:818, 1982.

    PubMed  CAS  Google Scholar 

  134. Kolker, AE, Becker, B: Epinephrine maculopathy. Arch Ophthal 79:552, 1968.

    PubMed  CAS  Google Scholar 

  135. Michels, RG, Maumenee, AE: Cystoid macular edema associated with topically applied epinephrine in aphakic eyes. Am J Ophthal 80:379, 1975.

    PubMed  CAS  Google Scholar 

  136. Thomas, JV, Gragoudas, ES, Blair, NP, Lapus, JV: Correlation of epinephrine use and macular edema in aphakic glaucomatous eyes. Arch Ophthal 96:625, 1978.

    PubMed  CAS  Google Scholar 

  137. Miyake, K, Shirasawa, E, Hikita, M, et al: Synthesis of prostaglandin E in rabbit eyes with topically applied epinephrine. Invest Ophthal Vis Sci 29:332, 1988.

    PubMed  CAS  Google Scholar 

  138. Miyake, K, Kayazawa, F, Manabe, R, Miyake, Y: Indomethacin and the epinephrine-induced breakdown of the blood-ocular barrier in rabbits. Invest Ophthal Vis Sci 28:482, 1987.

    PubMed  CAS  Google Scholar 

  139. Hull, DS, Chemotti, T, Edelhauser, HF, et al: Effect of epinephrine on the corneal endothelium. Am J Ophthal 79:245, 1975.

    PubMed  CAS  Google Scholar 

  140. Edelhauser, HF, Hyndiuk, RA, Zeeb, A, Schultz, RO: Corneal edema and the intraocular use of epinephrine. Am J Ophthal 93:327, 1982.

    PubMed  CAS  Google Scholar 

  141. Waltman, SR, Yarian, D, Hart, W Jr, Becker, B: Cornealendothelial changes with long-term topical epinephrine therapy. Arch Ophthal 95:1357, 1977.

    PubMed  CAS  Google Scholar 

  142. Kramer, SG: Considerations on epinephrine therapy in glaucoma. Ann Ophthal 10:1077, 1978.

    PubMed  CAS  Google Scholar 

  143. Kramer, SG: Epinephrine distribution after topical administration to phakic and aphakic eyes. Trans Am Ophthal Soc 78:947, 1980.

    PubMed  CAS  Google Scholar 

  144. Morgan, TR, Mirate, DJ, Bowman, K, Green, K: Topical epinephrine and regional ocular blood flow in aphakic eyes of rabbits. Arch Ophthal 101:112, 1983.

    PubMed  CAS  Google Scholar 

  145. Jay, WM, Aziz, MZ, Green, K: The effect of retrobulbar epinephrine injection on ocular and optic nerve blood flow. Curr Eye Res 4:55, 1985.

    PubMed  CAS  Google Scholar 

  146. Stefansson, E, Robinson, D, Wolbarsht, ML, et al: Effect of epinephrine on PO2 in anterior chamber. Arch Ophthal 101:636, 1983.

    PubMed  CAS  Google Scholar 

  147. Harrison, R, Kaufmann, CS: Clonidine. Effects of a topically administered solution on intraocular pressure and blood pressure in open-angle glaucoma. Arch Ophthal 95:1368, 1977.

    PubMed  CAS  Google Scholar 

  148. Hodapp, E, Kolker, AE, Kass, MA, et al: The effect of topical clonidine on intraocular pressure. Arch Ophthal 99:1208, 1981.

    PubMed  CAS  Google Scholar 

  149. Petursson, G, Cole, R, Hanna, C: Treatment of glaucoma using minidrops of clonidine. Arch Ophthal 102:1180, 1984.

    PubMed  CAS  Google Scholar 

  150. Krieglstein, GK, Langham, ME, Leydhecker, W: The peripheral and central neural actions of clonidine in normal and glaucomatous eyes. Invest Ophthal Vis Sci 17:149, 1978.

    PubMed  CAS  Google Scholar 

  151. Lee, DA, Topper, JE, Brubaker, RF: Effect of clonidine on aqueous humor flow in normal human eyes. Exp Eye Res 38:239, 1984.

    PubMed  CAS  Google Scholar 

  152. Macri, FJ, Cevario, SJ: Clonidine. Effects on aqueous humor formation and intraocular pressure. Arch Ophthal 96:2111, 1978.

    PubMed  CAS  Google Scholar 

  153. Marquardt, R, Pillunat, LE, Stodtmeister, R: Ocular hemodynamics following local application of clonidine. Klin Monatsbl Augenheilkd 193:637, 1988.

    PubMed  CAS  Google Scholar 

  154. Coleman, AL, Robin, AL, Pollack, IP, et al: Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine. Arch Ophthal 108:1264, 1990.

    PubMed  CAS  Google Scholar 

  155. Gharagozloo, NZ, Relf, SJ, Brubaker, RF: Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145). Ophthalmology 95:1217, 1988.

    PubMed  CAS  Google Scholar 

  156. Wang, R-F, Camras, CB, Podos, SM, et al: The role of prostaglandins in the para-aminoclonidine-induced reduction of intraocular pressure. Trans Am Ophthal Soc 87:94, 1989.

    PubMed  CAS  Google Scholar 

  157. Jampel, HD, Robin, AL, Quigley, HA, Pollack, IP: Apraclonidine. A one-week dose-response study. Arch Ophthal 106:1069, 1988.

    PubMed  CAS  Google Scholar 

  158. Abrams, DA, Robin, AL, Crandall, AS, et al: A limited comparison of apraclonidine’s dose response in subjects with normal or increased intraocular pressure. Am J Oph thal 108:230, 1989.

    CAS  Google Scholar 

  159. Robin, AL: Short-term effects of unilateral 1% apraclonidine therapy. Arch Ophthal 106:912, 1988.

    PubMed  CAS  Google Scholar 

  160. Abraras, DA, Robin, AL, Pollack, IP, et al: The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydro-chloride) in normal volunteers. Arch Ophthal 105:1205, 1987.

    Google Scholar 

  161. Sugiyama, K, Kitazawa, Y, Kawai, K: Apraclonidine effects on ocular responses to YAG laser irradiation to the rabbit iris. Invest Ophthal Vis Sci 31:708,1990.

    PubMed  CAS  Google Scholar 

  162. Brown, RH, Stewart, RH, Lynch, MG, et al: ALO 2145 reduces the intraocular pressure elevation after anterior segment laser surgery. Ophthalmology 95:378, 1988.

    PubMed  CAS  Google Scholar 

  163. Kitazawa, Y, Taniguchi, T, Sugiyama, K: Use of apraclonidine to reduce acute intraocular pressure rise following Q-switched Nd:YAG laser iridotomy. Ophthal Surg 20:49, 1989.

    CAS  Google Scholar 

  164. Sridharrao, B, Badrinath, SS: Efficacy and safety of apraclonidine in patients undergoing anterior segment laser surgery. Br J Ophthal 73:884, 1989.

    CAS  Google Scholar 

  165. Pollack, IP, Brown, RH, Crandall, AS, et al: Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine. Arch Ophthal 106:754, 1988.

    PubMed  CAS  Google Scholar 

  166. Krawitz, PL, Podos, SM: Use of apraclonidine in the treatment of acute angle closure glaucoma. Arch Ophthal 108:1208, 1990.

    PubMed  CAS  Google Scholar 

  167. Morrison, JC, Robin, AL: Adjunctive glaucoma therapy. A comparison of apraclonidine to dipivefrin when added to timolol maleate. Ophthalmology 96:3, 1989.

    PubMed  CAS  Google Scholar 

  168. King, MH, Richards, DW: Near syncope and chest tightness after administration of apraclonidine before argon laser iri dotomy. Am J Ophthal 110:308, 1990.

    PubMed  CAS  Google Scholar 

  169. Serdahl, CL, Galustian, J, Lewis, RA: The effects of apraclonidine on conjunctival oxygen tension. Arch Ophthal 107:1777, 1989.

    PubMed  CAS  Google Scholar 

  170. Pollack, IP, Rossi, H: Norepinephrine in treatment of ocular hypertension and glaucoma. Arch Ophthal 93:173, 1975.

    PubMed  CAS  Google Scholar 

  171. Pollack, IP: Effect of 1-norepinephrine and adrenergic potentiators on the aqueous humor dynamics of man. Am J Ophthal 76:641, 1973.

    PubMed  CAS  Google Scholar 

  172. Potter, DE, Rowland, JM: Adrenergic drugs and intraocular pressure: effects of selective beta-adrenergic agonists. Exp Eye Res 27:615, 1978.

    PubMed  CAS  Google Scholar 

  173. Waitzman, MB, Woods, WD, Cheek, WV: Effects of prostaglandins and norepinephrine on ocular pressure and pupil size in rabbits following bilateral cervical ganglionectomy. Invest Ophthal Vis Sci 18:52, 1979.

    PubMed  CAS  Google Scholar 

  174. Colansanti, BK, Barany, EH: Potentiation of the mydriatic effect of norepinephrine in the rabbit after monoamine oxi-dase inhibition. Invest Ophthal Vis Sci 18:200, 1979.

    Google Scholar 

  175. Kitazawa, Y: Topical adrenergic potentiators in primary open-angle glaucoma. Am J Ophthal 74:588, 1972.

    PubMed  CAS  Google Scholar 

  176. Stewart, RH, Kimbrough, RL, Martin, PA, et al: Norepinephrine dipivalylate dose-response in ocular hypertensive subjects. Ann Ophthal 13:1279, 1981.

    PubMed  CAS  Google Scholar 

  177. Duffin, RM, Christensen, RE, Bergamini, MVW: Suppression of adrenergic adaptation in the eye with a prostaglan-din synthesis inhibitor. Invest Ophthal Vis Sci 21:756, 1981.

    PubMed  CAS  Google Scholar 

  178. Zeller, EA, Shoch, D, Cooperman, SG, Schnipper, RI: En-zymology of the refractory media of the eye. IX. On the role of monoamine oxidase in the regulation of aqueous humor dynamics of the rabbit eye. Invest Ophthal 6:618, 1967.

    PubMed  CAS  Google Scholar 

  179. Zeller, EA, Shoch, D, Czerner, TB, et al: Enzymology of the refractory media of the eye. X. Effects of topically admini stered bradykinin, amine releasers, and pargyline on aqueous humor dynamics. Invest Ophthal 10:274, 1971.

    PubMed  CAS  Google Scholar 

  180. Bausher, LP: Identification of A and B forms of monoami ne oxidase in the iris-ciliary body, superior cervical gangli on, and pineal gland of albino rabbits. Invest Ophthal 15:529, 1976.

    PubMed  CAS  Google Scholar 

  181. Mehra, KS, Roy, PN, Singh, R: Pargyline drops in glaucoma. Arch Ophthal 92:453, 1974.

    PubMed  CAS  Google Scholar 

  182. Ross, RA, Drance, SM: Effects of topically applied isoproterenol on aqueous dynamics in man. Arch Ophthal 83:39, 1970.

    PubMed  CAS  Google Scholar 

  183. Seidehamel, RJ, Dungan, KW, Hickey, TE: Specific hypotensive and antihypertensive ocular effects of d-isoproterenol in rabbits. Am J Ophthal 79:1018, 1975.

    PubMed  CAS  Google Scholar 

  184. Kass, MA, Reid, TW, Neufeld, AH, et al: The effect of d-isoproterenol on intraocular pressure of the rabbit, monkey, and man. Invest Ophthal 15:113, 1976.

    PubMed  CAS  Google Scholar 

  185. Brubaker, RF, Gaasterland, D: The effect of isoproterenol on aqueous humor formation in humans. Invest Ophthal Vis Sci 25:357, 1984.

    PubMed  CAS  Google Scholar 

  186. Caprioli, J, Sears, M, Bausher, L, et al: Forskolin lowers in traocular pressure by reducing aqueous inflow. Invest Ophthal Vis Sci 25:268, 1984.

    PubMed  CAS  Google Scholar 

  187. Jumblatt, JE, North, GT: Potentiation of sympathetic neurosecretion by forskolin and cyclic AMP in the rabbit irisciliary body. Curr Eye Res 5:495, 1986.

    PubMed  CAS  Google Scholar 

  188. Lee, P-Y, Podos, SM, Mittag, T, Severin, C: Effect of topically applied forskolin on aqueous humor dynamics in cynomolgus monkey. Invest Ophthal Vis Sci 25:1206, 1984.

    PubMed  CAS  Google Scholar 

  189. Badian, M, Dabrowski, J, Grigoleit, H-G, et al: Effect of forskolin-eyedrops on the intraocular pressure of healthy male subjects. Klin Monatsbl Augenheilkd 185:522, 1984.

    PubMed  CAS  Google Scholar 

  190. Caprioli, J, Sears, M: Combined effect of forskolin and acetazolamide on intraocular pressure and aqueous flow in rabbit eyes. Exp Eye Res 39:47, 1984.

    PubMed  CAS  Google Scholar 

  191. Burstein, NL, Sears, ML, Mead, A: Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator. Exp Eye Res 39:745, 1984.

    PubMed  CAS  Google Scholar 

  192. Bartels, SP, Lee, SR, Neufeld, AH: The effects of forskolin on cyclic AMP, intraocular pressure and aqueous humor formation in rabbits. Curr Eye Res 6:307, 1987.

    PubMed  CAS  Google Scholar 

  193. Brubaker, RF, Carlson, KH, Kullerstrand, LJ, McLaren, JW: Topical forskolin (Colforsin) and aqueous flow in humans. Arch Ophthal 105:637, 1987.

    PubMed  CAS  Google Scholar 

  194. Shibata, T, Mishima, H, Kurokawa, T: Ocular pigmentation and intraocular pressure response to forskolin. Curr Eye Res 7:667, 1988.

    PubMed  CAS  Google Scholar 

  195. Gregory, D, Sears, M, Bausher, L, et al: Intraocular pressure and aqueous flow are decreased by cholera toxin. Invest Ophthal Vis Sci 20:371, 1981.

    PubMed  CAS  Google Scholar 

  196. Bartels, SP, Roth, HO, Neufeld, AH: Effects of intravitreal cholera toxin on adenosine 3’, 5’-monophosphate, intraocular pressure, and outflow facility in rabbits. Invest Ophthal Vis Sci 20:410, 1981.

    CAS  Google Scholar 

  197. Mishima, H, Sears, M, Bausher, L, Gregory, D: Ultracytochemistry of cholera-toxin binding sites in ciliary processes. Cell Tissue Res 223:241, 1982.

    PubMed  CAS  Google Scholar 

  198. Mishima, H, Bausher, L, Sears, M, et al: Fine structural studies of ciliary processes after treatment with cholera toxin or its B subunit. Graefe’s Arch Ophthal 219:272, 1982.

    CAS  Google Scholar 

  199. Bonomi, L, Perfetti, S, Bellucci, R, Massa, F: Effects of terbutaline on experimentally induced ocular hypertension in the rabbit. Glaucoma 4:134, 1982.

    Google Scholar 

  200. Bonomi, L, Perfetti, S, Bellucci, R, et al: Prevention by diclofenac of the subsensitivity to the IOP-lowering effect of terbutaline. Glaucoma 6:241, 1984.

    Google Scholar 

  201. Bonomi, L, Perfetti, S, Bellucci, R, et al: Intraocular pressure lowering effect of ibuterol in the rabbit. Glaucoma 6:216, 1984.

    Google Scholar 

  202. Coakes, RL, Siah, PB: Effects of adrenergic drugs on aqueous humour dynamics in the normal human eye. I. Sal-butamol. Br J Ophthal 68:393, 1984.

    CAS  Google Scholar 

  203. Mittag, TW, Tormay, A, Messenger, M, Podos, SM: Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin. Invest Ophthal Vis Sci 26:163, 1985.

    PubMed  CAS  Google Scholar 

  204. Krupin, T, Becker, B, Podos, SM: Topica vanadate lowers intraocular pressure in rabbits. Invest Ophthal Vis Sci 19:1360, 1980.

    PubMed  CAS  Google Scholar 

  205. Podos, SM, Lee, P-Y, Severin, C, Mittag, T: The effect of vanadate on aqueous humor dynamics in cynomolgus monkeys. Invest Ophthal Vis Sci 25:359, 1984.

    PubMed  CAS  Google Scholar 

  206. Becker, B: Vanadate and aqueous humor dynamics. Invest Ophthal Vis Sci 19:1156, 1980.

    PubMed  CAS  Google Scholar 

  207. Mittag, TW, Serle, JB, Podos, SM, et al: Vanadate effects on ocular pressure, (Na+, K+) ATPase and adenylate cyclase in rabbit eyes. Invest Ophthal Vis Sci 25:1335, 1984.

    PubMed  CAS  Google Scholar 

  208. Sobel, L, Serle, JB, Podos, SM, et al: Topical nylidrin and aqueous humor dynamics in rabbits and monkeys. Arch Ophthal 101:1281, 1983.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophtalmology, Duke University Medical Center, Durham, NC, 27710, USA

    Prof. Dr. M. Bruce Shields

  2. Direktor der Universitäts-Augenklinik Köln, Joseph-Stelzmann-Straße 9, 50931, Köln, Deutschland

    Prof. Dr. Günter Karl Krieglstein

Authors
  1. Prof. Dr. M. Bruce Shields
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. Günter Karl Krieglstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Shields, M.B., Krieglstein, G.K. (1993). Sympathomimetika. In: Glaukom. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77053-1_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77053-1_26

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77054-8

  • Online ISBN: 978-3-642-77053-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation